These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 1871801
1. Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients. Kunzendorf U, Walz G, Brockmoeller J, Neumayer HH, Jochimsen F, Roots I, Offermann G, Strom TB. Transplantation; 1991 Aug; 52(2):280-4. PubMed ID: 1871801 [Abstract] [Full Text] [Related]
2. Modulation of human peripheral blood mononuclear cell proliferative response by diltiazem : in vitro comparison in younger versus older subjects. D'Ambrosio A, Giordani L, Colucci M, Vanacore N, Quintieri F. Drugs Aging; 2009 Aug; 26(1):87-94. PubMed ID: 19102517 [Abstract] [Full Text] [Related]
4. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients. Yoshimura N, Kahan BD. Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806 [Abstract] [Full Text] [Related]
9. The impact of high lymphocyte sensitivity to glucocorticoids on kidney graft survival in patients treated with azathioprine and cyclosporine. Langhoff E, Ladefoged J. Transplantation; 1987 Mar; 43(3):380-4. PubMed ID: 3547794 [Abstract] [Full Text] [Related]
12. Long-term follow-up of co-administration of diltiazem and cyclosporine in Chinese kidney transplant recipients. Xue W, Ding X, Tian P, Pan X, Yan H, Hou J, Feng X, Xiang H, Tian X. Ren Fail; 2010 Jan; 32(3):314-9. PubMed ID: 20370446 [Abstract] [Full Text] [Related]
13. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro. Rayat G, Yatscoff R, Silverman R, McKenna R. Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482 [Abstract] [Full Text] [Related]
14. A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome. Patton PR, Brunson ME, Pfaff WW, Howard RJ, Peterson JC, Ramos EL, Karlix JL. Transplantation; 1994 Mar 27; 57(6):889-92. PubMed ID: 8154037 [Abstract] [Full Text] [Related]
15. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination. Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group. Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789 [Abstract] [Full Text] [Related]
17. Protective effects of diltiazem and the prostazycline analogue iloprost in human renal transplantation. Neumayer HH, Kunzendorf U, Schreiber M. Ren Fail; 1992 Dec 15; 14(3):289-96. PubMed ID: 1380721 [Abstract] [Full Text] [Related]
18. Short-term effects of calcium antagonists on hemodynamics and cyclosporine pharmacokinetics in heart-transplant and kidney-transplant patients. Roy LF, East DS, Browning FM, Shaw D, Ogilvie RI, Cardella C, Leenen FH. Clin Pharmacol Ther; 1989 Dec 15; 46(6):657-67. PubMed ID: 2689045 [Abstract] [Full Text] [Related]
19. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC. Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960 [Abstract] [Full Text] [Related]
20. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants. Redaelli CA, Wagner M, Günter-Duwe D, Tian YH, Stahel PF, Mazzucchelli L, Schmid RA, Schilling MK. Kidney Int; 2002 Jan 15; 61(1):288-96. PubMed ID: 11786111 [Abstract] [Full Text] [Related] Page: [Next] [New Search]